Bruno L Ferreyro1,2,3, Federico Angriman1,2,4, Laveena Munshi2,3, Lorenzo Del Sorbo1,5, Niall D Ferguson1,2,3, Bram Rochwerg6, Michelle J Ryu7, Refik Saskin8, Hannah Wunsch1,2,4,8, Bruno R da Costa2,9,10, Damon C Scales1,2,4,8,9. 1. Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada. 2. Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 3. Department of Medicine, Sinai Health System and University Health Network, Toronto, Ontario, Canada. 4. Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 5. Division of Respirology, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada. 6. Department of Medicine, Division of Critical Care, and Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada. 7. Sidney Liswood Health Science Library, Mount Sinai Hospital, Toronto, Ontario, Canada. 8. Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. 9. Applied Health Research Center (AHRC), Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada. 10. Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Abstract
Importance: Treatment with noninvasive oxygenation strategies such as noninvasive ventilation and high-flow nasal oxygen may be more effective than standard oxygen therapy alone in patients with acute hypoxemic respiratory failure. Objective: To compare the association of noninvasive oxygenation strategies with mortality and endotracheal intubation in adults with acute hypoxemic respiratory failure. Data Sources: The following bibliographic databases were searched from inception until April 2020: MEDLINE, Embase, PubMed, Cochrane Central Register of Controlled Trials, CINAHL, Web of Science, and LILACS. No limits were applied to language, publication year, sex, or race. Study Selection: Randomized clinical trials enrolling adult participants with acute hypoxemic respiratory failure comparing high-flow nasal oxygen, face mask noninvasive ventilation, helmet noninvasive ventilation, or standard oxygen therapy. Data Extraction and Synthesis: Two reviewers independently extracted individual study data and evaluated studies for risk of bias using the Cochrane Risk of Bias tool. Network meta-analyses using a bayesian framework to derive risk ratios (RRs) and risk differences along with 95% credible intervals (CrIs) were conducted. GRADE methodology was used to rate the certainty in findings. Main Outcomes and Measures: The primary outcome was all-cause mortality up to 90 days. A secondary outcome was endotracheal intubation up to 30 days. Results: Twenty-five randomized clinical trials (3804 participants) were included. Compared with standard oxygen, treatment with helmet noninvasive ventilation (RR, 0.40 [95% CrI, 0.24-0.63]; absolute risk difference, -0.19 [95% CrI, -0.37 to -0.09]; low certainty) and face mask noninvasive ventilation (RR, 0.83 [95% CrI, 0.68-0.99]; absolute risk difference, -0.06 [95% CrI, -0.15 to -0.01]; moderate certainty) were associated with a lower risk of mortality (21 studies [3370 patients]). Helmet noninvasive ventilation (RR, 0.26 [95% CrI, 0.14-0.46]; absolute risk difference, -0.32 [95% CrI, -0.60 to -0.16]; low certainty), face mask noninvasive ventilation (RR, 0.76 [95% CrI, 0.62-0.90]; absolute risk difference, -0.12 [95% CrI, -0.25 to -0.05]; moderate certainty) and high-flow nasal oxygen (RR, 0.76 [95% CrI, 0.55-0.99]; absolute risk difference, -0.11 [95% CrI, -0.27 to -0.01]; moderate certainty) were associated with lower risk of endotracheal intubation (25 studies [3804 patients]). The risk of bias due to lack of blinding for intubation was deemed high. Conclusions and Relevance: In this network meta-analysis of trials of adult patients with acute hypoxemic respiratory failure, treatment with noninvasive oxygenation strategies compared with standard oxygen therapy was associated with lower risk of death. Further research is needed to better understand the relative benefits of each strategy.
Importance: Treatment with noninvasive oxygenation strategies such as noninvasive ventilation and high-flow nasal oxygen may be more effective than standard oxygen therapy alone in patients with acute hypoxemic respiratory failure. Objective: To compare the association of noninvasive oxygenation strategies with mortality and endotracheal intubation in adults with acute hypoxemic respiratory failure. Data Sources: The following bibliographic databases were searched from inception until April 2020: MEDLINE, Embase, PubMed, Cochrane Central Register of Controlled Trials, CINAHL, Web of Science, and LILACS. No limits were applied to language, publication year, sex, or race. Study Selection: Randomized clinical trials enrolling adult participants with acute hypoxemic respiratory failure comparing high-flow nasal oxygen, face mask noninvasive ventilation, helmet noninvasive ventilation, or standard oxygen therapy. Data Extraction and Synthesis: Two reviewers independently extracted individual study data and evaluated studies for risk of bias using the Cochrane Risk of Bias tool. Network meta-analyses using a bayesian framework to derive risk ratios (RRs) and risk differences along with 95% credible intervals (CrIs) were conducted. GRADE methodology was used to rate the certainty in findings. Main Outcomes and Measures: The primary outcome was all-cause mortality up to 90 days. A secondary outcome was endotracheal intubation up to 30 days. Results: Twenty-five randomized clinical trials (3804 participants) were included. Compared with standard oxygen, treatment with helmet noninvasive ventilation (RR, 0.40 [95% CrI, 0.24-0.63]; absolute risk difference, -0.19 [95% CrI, -0.37 to -0.09]; low certainty) and face mask noninvasive ventilation (RR, 0.83 [95% CrI, 0.68-0.99]; absolute risk difference, -0.06 [95% CrI, -0.15 to -0.01]; moderate certainty) were associated with a lower risk of mortality (21 studies [3370 patients]). Helmet noninvasive ventilation (RR, 0.26 [95% CrI, 0.14-0.46]; absolute risk difference, -0.32 [95% CrI, -0.60 to -0.16]; low certainty), face mask noninvasive ventilation (RR, 0.76 [95% CrI, 0.62-0.90]; absolute risk difference, -0.12 [95% CrI, -0.25 to -0.05]; moderate certainty) and high-flow nasal oxygen (RR, 0.76 [95% CrI, 0.55-0.99]; absolute risk difference, -0.11 [95% CrI, -0.27 to -0.01]; moderate certainty) were associated with lower risk of endotracheal intubation (25 studies [3804 patients]). The risk of bias due to lack of blinding for intubation was deemed high. Conclusions and Relevance: In this network meta-analysis of trials of adult patients with acute hypoxemic respiratory failure, treatment with noninvasive oxygenation strategies compared with standard oxygen therapy was associated with lower risk of death. Further research is needed to better understand the relative benefits of each strategy.
Authors: T J Martin; J D Hovis; J P Costantino; M I Bierman; M P Donahoe; R M Rogers; J W Kreit; F C Sciurba; R A Stiller; M H Sanders Journal: Am J Respir Crit Care Med Date: 2000-03 Impact factor: 21.405
Authors: C Delclaux; E L'Her; C Alberti; J Mancebo; F Abroug; G Conti; C Guérin; F Schortgen; Y Lefort; M Antonelli; E Lepage; F Lemaire; L Brochard Journal: JAMA Date: 2000-11-08 Impact factor: 56.272
Authors: Giacomo Bellani; John G Laffey; Tài Pham; Fabiana Madotto; Eddy Fan; Laurent Brochard; Andres Esteban; Luciano Gattinoni; Vesna Bumbasirevic; Lise Piquilloud; Frank van Haren; Anders Larsson; Daniel F McAuley; Philippe R Bauer; Yaseen M Arabi; Marco Ranieri; Massimo Antonelli; Gordon D Rubenfeld; B Taylor Thompson; Hermann Wrigge; Arthur S Slutsky; Antonio Pesenti Journal: Am J Respir Crit Care Med Date: 2017-01-01 Impact factor: 21.405
Authors: João João Mendes; José Artur Paiva; Filipe Gonzalez; Paulo Mergulhão; Filipe Froes; Roberto Roncon; João Gouveia Journal: Rev Bras Ter Intensiva Date: 2022-01-24
Authors: Andrew J E Seely; Bram Rochwerg; Shannon M Fernando; Alexandre Tran; Behnam Sadeghirad; Karen E A Burns; Eddy Fan; Daniel Brodie; Laveena Munshi; Ewan C Goligher; Deborah J Cook; Robert A Fowler; Margaret S Herridge; Pierre Cardinal; Samir Jaber; Morten Hylander Møller; Arnaud W Thille; Niall D Ferguson; Arthur S Slutsky; Laurent J Brochard Journal: Intensive Care Med Date: 2021-11-25 Impact factor: 17.440
Authors: Lieuwe D J Bos; Antonio Artigas; Jean-Michel Constantin; Laura A Hagens; Nanon Heijnen; John G Laffey; Nuala Meyer; Laurent Papazian; Lara Pisani; Marcus J Schultz; Manu Shankar-Hari; Marry R Smit; Charlotte Summers; Lorraine B Ware; Raffaele Scala; Carolyn S Calfee Journal: Eur Respir Rev Date: 2021-02-02
Authors: Pedro D Wendel Garcia; Hernán Aguirre-Bermeo; Philipp K Buehler; Mario Alfaro-Farias; Bernd Yuen; Sascha David; Thomas Tschoellitsch; Tobias Wengenmayer; Anita Korsos; Alberto Fogagnolo; Gian-Reto Kleger; Maddalena A Wu; Riccardo Colombo; Fabrizio Turrini; Antonella Potalivo; Emanuele Rezoagli; Raquel Rodríguez-García; Pedro Castro; Arantxa Lander-Azcona; Maria C Martín-Delgado; Herminia Lozano-Gómez; Rolf Ensner; Marc P Michot; Nadine Gehring; Peter Schott; Martin Siegemund; Lukas Merki; Jan Wiegand; Marie M Jeitziner; Marcus Laube; Petra Salomon; Frank Hillgaertner; Alexander Dullenkopf; Hatem Ksouri; Sara Cereghetti; Serge Grazioli; Christian Bürkle; Julien Marrel; Isabelle Fleisch; Marie-Helene Perez; Anja Baltussen Weber; Samuele Ceruti; Katharina Marquardt; Tobias Hübner; Hermann Redecker; Michael Studhalter; Michael Stephan; Daniela Selz; Urs Pietsch; Anette Ristic; Antje Heise; Friederike Meyer Zu Bentrup; Marilene Franchitti Laurent; Patricia Fodor; Tomislav Gaspert; Christoph Haberthuer; Elif Colak; Dorothea M Heuberger; Thierry Fumeaux; Jonathan Montomoli; Philippe Guerci; Reto A Schuepbach; Matthias P Hilty; Ferran Roche-Campo Journal: Crit Care Date: 2021-05-25 Impact factor: 9.097
Authors: Kieran P Nunn; Murray J Blackstock; Ryan Ellis; Gauhar Sheikh; Alastair Morgan; Jonathan K J Rhodes Journal: Case Rep Crit Care Date: 2021-05-24
Authors: Iain S Forrest; Suraj K Jaladanki; Ishan Paranjpe; Benjamin S Glicksberg; Girish N Nadkarni; Ron Do Journal: Infection Date: 2021-06-05 Impact factor: 3.553
Authors: Michael Madekurozwa; Willy V Bonneuil; Jennifer Frattolin; Daniel J Watson; Axel C Moore; Molly M Stevens; James Moore; Jakob Mathiszig-Lee; Joseph van Batenburg-Sherwood Journal: Front Med Technol Date: 2021-10-04